Search research articles
Contact Us
Filters
Showing results (31-40 of 50) with videos related to
Page
of 5
Sort By:
Minerva Medica
|
January 28, 1982
[Approach to the problem of economic costs of the medical therapy of tumors]
G F Garusi, R Demicheli, A Jirillo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 14, 2008
The effects of surgery on tumor growth: a century of investigations
R Demicheli, M W Retsky, W J M Hrushesky, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
October 7, 2008
Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancer
M W Retsky, R Demicheli, W J M Hrushesky, et al.
Tumori
|
February 28, 1985
Pharmacologic data and technical feasibility of intraperitoneal doxorubicin administration
R Demicheli, G Bonciarelli, A Jirillo, et al.
Tumori
|
October 31, 1987
Pilot study of intravenous administration of the acid-treated Salmonella minnesota R595 (Re) in cancer patients
A Jirillo, A Disperati, M Balli, et al.
Acta Anaesthesiologica Belgica
|
June 18, 2013
Is there a rationale for an anesthesiologist's role against cancer recurrence?
P Forget, P G Coulie, M Retsky, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 1, 1996
Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma. A phase II trial of 22 patients
L Licitra, R Cavina, C Grandi, et al.
Tumori
|
October 31, 1982
Pharmacological data and technical feasibility of intraperitoneal 5-fluorouracil administration
R Demicheli, A Jirillo, G Bonciarelli, et al.
Breast Cancer Research and Treatment
|
June 16, 1999
Comparative analysis of breast cancer recurrence risk for patients receiving or not receiving adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF). Data supporting the occurrence of 'cures'
R Demicheli, R Miceli, C Brambilla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 1993
Drugs ten years later: epirubicin
G Bonadonna, L Gianni, A Santoro, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 50) with videos related to
Sort By:
Page
of 5
Minerva Medica
|
January 28, 1982
[Approach to the problem of economic costs of the medical therapy of tumors]
G F Garusi, R Demicheli, A Jirillo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 14, 2008
The effects of surgery on tumor growth: a century of investigations
R Demicheli, M W Retsky, W J M Hrushesky, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
October 7, 2008
Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancer
M W Retsky, R Demicheli, W J M Hrushesky, et al.
Tumori
|
February 28, 1985
Pharmacologic data and technical feasibility of intraperitoneal doxorubicin administration
R Demicheli, G Bonciarelli, A Jirillo, et al.
Tumori
|
October 31, 1987
Pilot study of intravenous administration of the acid-treated Salmonella minnesota R595 (Re) in cancer patients
A Jirillo, A Disperati, M Balli, et al.
Acta Anaesthesiologica Belgica
|
June 18, 2013
Is there a rationale for an anesthesiologist's role against cancer recurrence?
P Forget, P G Coulie, M Retsky, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 1, 1996
Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma. A phase II trial of 22 patients
L Licitra, R Cavina, C Grandi, et al.
Tumori
|
October 31, 1982
Pharmacological data and technical feasibility of intraperitoneal 5-fluorouracil administration
R Demicheli, A Jirillo, G Bonciarelli, et al.
Breast Cancer Research and Treatment
|
June 16, 1999
Comparative analysis of breast cancer recurrence risk for patients receiving or not receiving adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF). Data supporting the occurrence of 'cures'
R Demicheli, R Miceli, C Brambilla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 1993
Drugs ten years later: epirubicin
G Bonadonna, L Gianni, A Santoro, et al.
Page
of 5